Interstitial and orphan lung disease

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on
Effrosyni D. Manali, Matthias Griese, Spyros A. Papiris

ERJ Open Research Nov 2023, 9 (6) 00646-2023; DOI: 10.1183/23120541.00646-2023
Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system
Julien Bermudez, Nadia Nathan, Benjamin Coiffard, Antoine Roux, Sandrine Hirschi, Tristan Degot, Vincent Bunel, Jérôme Le Pavec, Julie Macey, Aurélie Le Borgne, Marie Legendre, Vincent Cottin, Pascal-Alexandre Thomas, Raphaël Borie, Martine Reynaud-Gaubert

ERJ Open Research Nov 2023, 9 (6) 00240-2023; DOI: 10.1183/23120541.00240-2023
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension
Gina Parcesepe, Richard J. Allen, Beatriz Guillen-Guio, Samuel Moss, R. Gisli Jenkins, Louise V. Wain

ERJ Open Research Nov 2023, 9 (6) 00457-2023; DOI: 10.1183/23120541.00457-2023
Compartment-specific protein interactions in beryllium lung disease
Li Li, Brian Vestal, Margaret M. Mroz, Sucai Liu, Kristyn MacPhail, Tim J. Griffin, Ivana V. Yang, Lisa A. Maier, Maneesh Bhargava

ERJ Open Research Nov 2023, 9 (6) 00138-2023; DOI: 10.1183/23120541.00138-2023
Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can't see the forest for the trees!
Alice Castaldo, Celine Delestrain, Rémi Diesler, Claire Merveilleux du Vignaux, Marion Onnee, Renaud Touraine, Lara Chalabreysse, Pascale Fanen, Ralph Epaud, Vincent Cottin, Alix De Becdelièvre

ERJ Open Research Nov 2023, 9 (6) 00472-2023; DOI: 10.1183/23120541.00472-2023
Altered macrophage phenotypes in a case of autoimmune pulmonary alveolar proteinosis
Kentaro Hata, Toyoshi Yanagihara, Keisuke Matsubara, Kazufumi Kunimura, Daisuke Eto, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshinori Fukui, Isamu Okamoto

ERJ Open Research Sep 2023, 9 (5) 00500-2023; DOI: 10.1183/23120541.00500-2023
Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases
Yixuan Zou, Xuefeng Hou, Neha Anegondi, Mohammadreza Negahdar, Dorothy Cheung, Paula Belloni, Alex de Crespigny, Alexandre Fernandez Coimbra

ERJ Open Research Sep 2023, 9 (5) 00210-2023; DOI: 10.1183/23120541.00210-2023
High prevalence of interstitial lung abnormalities in middle-aged never-smokers
Ida Pesonen, Fredrik Johansson, Åse Johnsson, Anders Blomberg, Marianne Boijsen, John Brandberg, Kerstin Cederlund, Arne Egesten, Össur Ingi Emilsson, Jan E. Engvall, Andreas Frølich, Emil Hagström, Eva Lindberg, Andrei Malinovschi, Nikolai Stenfors, Eva Swahn, Hanan Tanash, Raquel Themudo, Kjell Torén, Lowie E.G.W. Vanfleteren, Per Wollmer, Suneela Zaigham, Carl Johan Östgren, C. Magnus Sköld

ERJ Open Research Sep 2023, 9 (5) 00035-2023; DOI: 10.1183/23120541.00035-2023
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis
Thijs W. Hoffman, Coline H.M. van Moorsel, Joanne J. van der Vis, Douwe H. Biesma, Jan C. Grutters

ERJ Open Research Sep 2023, 9 (5) 00131-2023; DOI: 10.1183/23120541.00131-2023
Interstitial lung abnormalities: do symptoms matter?
Avignat S. Patel

ERJ Open Research Sep 2023, 9 (5) 00502-2023; DOI: 10.1183/23120541.00502-2023

Main menu

User menu

Search

Interstitial and orphan lung disease

Pages

Contact us